These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32873569)

  • 1. Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma.
    Bassaganyas L; Pinyol R; Esteban-Fabró R; Torrens L; Torrecilla S; Willoughby CE; Franch-Expósito S; Vila-Casadesús M; Salaverria I; Montal R; Mazzaferro V; Camps J; Sia D; Llovet JM
    Clin Cancer Res; 2020 Dec; 26(23):6350-6361. PubMed ID: 32873569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
    Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
    Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
    Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
    Elife; 2020 Jan; 9():. PubMed ID: 31939734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of genomic and immunological profiles in Chinese and Western hepatocellular carcinoma populations.
    Li W; Wu H; Xu X; Zhang Y
    Aging (Albany NY); 2021 Apr; 13(8):11564-11594. PubMed ID: 33867349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
    Sia D; Jiao Y; Martinez-Quetglas I; Kuchuk O; Villacorta-Martin C; Castro de Moura M; Putra J; Camprecios G; Bassaganyas L; Akers N; Losic B; Waxman S; Thung SN; Mazzaferro V; Esteller M; Friedman SL; Schwartz M; Villanueva A; Llovet JM
    Gastroenterology; 2017 Sep; 153(3):812-826. PubMed ID: 28624577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease.
    Chappell G; Silva GO; Uehara T; Pogribny IP; Rusyn I
    Cancer Med; 2016 Mar; 5(3):574-85. PubMed ID: 26778414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
    Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
    EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAD51 High-Expressed Hepatocellular Carcinomas Are Associated With High Cell Proliferation.
    Takahashi K; Yan L; An N; Chida K; Tian W; Oshi M; Takabe K
    J Surg Res; 2024 Oct; 302():250-258. PubMed ID: 39111128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.
    Torrecilla S; Sia D; Harrington AN; Zhang Z; Cabellos L; Cornella H; Moeini A; Camprecios G; Leow WQ; Fiel MI; Hao K; Bassaganyas L; Mahajan M; Thung SN; Villanueva A; Florman S; Schwartz ME; Llovet JM
    J Hepatol; 2017 Dec; 67(6):1222-1231. PubMed ID: 28843658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.
    Gu DL; Chen YH; Shih JH; Lin CH; Jou YS; Chen CF
    World J Gastroenterol; 2013 Dec; 19(47):8873-9. PubMed ID: 24379610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlating genomic copy number alterations with clinicopathologic findings in 75 cases of hepatocellular carcinoma.
    Peng G; Chai H; Ji W; Lu Y; Wu S; Zhao H; Li P; Hu Q
    BMC Med Genomics; 2021 Jun; 14(1):150. PubMed ID: 34103027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution.
    Takeda H; Takai A; Kumagai K; Iguchi E; Arasawa S; Eso Y; Shimizu T; Ueda Y; Taura K; Uemoto S; Kita R; Haga H; Marusawa H; Fujimoto A; Seno H
    J Pathol; 2020 Dec; 252(4):398-410. PubMed ID: 32815153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses.
    Morisue R; Kojima M; Suzuki T; Nakatsura T; Ojima H; Watanabe R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Ishii G; Gotohda N; Fujiwara T; Ochiai A
    Int J Cancer; 2021 Aug; 149(3):546-560. PubMed ID: 33662146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma.
    Guo L; Yi X; Chen L; Zhang T; Guo H; Chen Z; Cheng J; Cao Q; Liu H; Hou C; Qi L; Zhu Z; Liu Y; Kong R; Zhang C; Zhou X; Zhang Z; Song T; Xue R; Zhang N
    Gastroenterology; 2022 Jan; 162(1):238-252. PubMed ID: 34481846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma.
    Chan AW; Zhang Z; Chong CC; Tin EK; Chow C; Wong N
    J Pathol; 2019 Oct; 249(2):166-172. PubMed ID: 31168847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss at 16q22.1 identified as a risk factor for intrahepatic recurrence in hepatocellular carcinoma and screening of differentially expressed genes.
    Chen L; Zhu ZZ; Liu SF; Wan X; Wen BJ; Jiang H; Zhu J; Cong WM
    Neoplasma; 2016; 63(1):114-20. PubMed ID: 26639241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
    Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
    Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative molecular analysis of metastatic hepatocellular carcinoma.
    Wang D; Zhu Y; Tang J; Lian Q; Luo G; Wen W; Zhang MQ; Wang H; Chen L; Gu J
    BMC Med Genomics; 2019 Nov; 12(1):164. PubMed ID: 31722693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
    Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.